Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 15, 2003

View Archived Issues

Advectus acquires option for nanopharmaceutical for Alzheimer's disease

Cell Therapeutics Scandinavia and Tanabe enter stem cell collaboration

Probactrix controls antibiotic-associated diarrhea in clinical study

Novel 5-HT6 receptor ligands claimed by GSK researchers

Pierre Fabre presents new alpha2-adrenoceptor modulators with potential in AD therapy

BMS scientists prepare and test new anti-HIV agents

Novel p38 inhibitors, their preparation and use covered by GSK patent

Roche identifies new DPP-IV inhibitors

AstraZeneca claims JNK inhibitors for use in AD and other disorders

Humira approved in E.U. for rheumatoid arthritis

Raptiva recommended for approval by advisory committee

Maxalt launched this month in Japan for migraine Rx

Potent antagonist of human glucagon receptor presented at ACS meeting

Selective ERbeta agonist endowed with potent oral antiinflammatory activity

OncoGenex and Isis expand antisense drug development partnership

AVE-5997, a selective, orally active dopamine D3 antagonist, characterized at ACS meeting

Regeneron to advance phase III Axokine program in obesity

Benicar HCT now available in U.S.

Javlor enters two new phase III trials in NSCLC and bladder cancer

BMS designs series of potent and selective Itk inhibitors as potential immunosuppressants

Enrollment completed in phase I breast cancer trial for HER-2 AutoVac Protein vaccine

Merck presents synthesis, SAR for a series of imidazole acetic acid TAFI inhibitors

FDA accepts for filing diquafosol NDA for dry eye

Phase III results for Genasense plus chemotherapy in malignant melanoma

Genzyme expands access to Myozyme

SBIR grant supports smallpox therapeutic development efforts at Aphios

New fluoroquinolone active against multidrug-resistant Gram-positive pathogens

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...